19 SEP 2026 · The CLARITY Act is dead for this legislative session after failing cloture 49-50, and the consequences for XRP are structural, not just sentimental. Today's episode opens with a clear-eyed analysis of what that vote actually killed: not XRP's existing legal standing from the Ripple-SEC outcome, but the statutory SEC-CFTC boundary that would have unlocked the next wave of institutional capital. That macro catalyst is now gone indefinitely, with no replacement vote scheduled.
On price action, XRP is ranging between $1.32 and $1.41 — a range built on short liquidations and Bitcoin's push past $81,000, not fundamental repricing. Futures volume of $5.71 billion against $1.36 billion in spot volume means the market is running more than four times leveraged to sentiment. When that sentiment shifts, the unwinding is fast. Support at $1.20–$1.30 is the line to watch.
Spot XRP ETF inflows have plateaued since the September launch near $3.08. Without statutory clarity, the institutional adoption timeline just stretched further. Meanwhile, broader crypto infrastructure stories are worth tracking: Coinbase Derivatives filed with the CFTC to offer cash-settled equity perpetuals, signalling where regulated institutional products are heading. 21Shares updated its Injective ETF S-1/A, proposing 40–60% INJ staking with BNY Mellon as administrator and a Nasdaq listing. Injective also integrated with Phantom wallet, driving a 17% INJ rally.
Finally, Goldman Sachs flagged slowing corporate profit growth as an equity market vulnerability. If equities re-rate lower, risk-off pressure moves through crypto fast. Three tests will define XRP's near term: holding $1.20 support, CLARITY's return or absence, and Bitcoin's momentum carrying past $1.45 resistance. This episode includes AI-generated content.